Paediatric Medicines: Formulation Considerations

Journal Title: Archives of Pharmacy and Pharmaceutical Sciences - Year 2017, Vol 1, Issue 1

Abstract

The use of unlicensed and off-label medicines in children is widespread and has raised an increasing concern over the last years. The majority of medicines taken by children are extemporaneously compounded by pharmacist, and there is a lack of information regarding bioavailability, suitability and stability. These formulations must be prepared from pure active substance and not from commercially available dosage forms. The development of paediatric formulations, particularly those suitable for very young children, can be a challenge to pharmacists. There is limited knowledge available about the acceptability of different dosage forms, administration volume, dosage form size, taste, safety of formulation excipients regarding to age and development status. The selection of formulation and route of administration depends on the disease being treated and the clinical condition. European Guidelines and reflection papers recommend that pharmaceutical development should consider some parameters like capability, acute or long-term illness, caregiver convenience, disability, culture differences and formulations more attractive to children must be explored.

Authors and Affiliations

Fátima Roque

Keywords

Related Articles

Application of the Pyphagor’s Theorem for Correction of Ki and Ka constants of enzyme inhibition and activation

The analysis of dependence of the length projection of Li vectors of biparametrical inhibited and activated (La) enzymatic reactions from the length projection of vectors of monoparametrical inhibited and activated enzym...

Paediatric Medicines: Formulation Considerations

The use of unlicensed and off-label medicines in children is widespread and has raised an increasing concern over the last years. The majority of medicines taken by children are extemporaneously compounded by pharmacist,...

Diazepam Withdrawal Expression is related to Hippocampal NOS-1 Upregulation

Background: Benzodiazepines are usually prescribed for anxiety and sleep disorders in a long-term fashion that may cause drug dependence. Discontinuation after prolonged administration may lead to withdrawal expression,...

Preparation, solid state characterization and evaluation of ketoprofen-glucosamine HCl solid dispersions

In this investigation, solid dispersions were prepared and characterized to improve the solubility and dissolution of poorly water soluble drug Ketoprofen, using glucosamine HCl as a carrier. For the improvement of the s...

Biologic therapy-Related demyelinating peripheral neuropathy in a child with Juvenile Idiopathic Arthritis

Demyelinating peripheral neuropathy has been described in association with tumor necrosis factor (TNF) inhibitors. It is rarely developed after treatment discontinuation. We present the case of a child with juvenile idio...

Download PDF file
  • EP ID EP560269
  • DOI 10.29328/journal.hps.1001004
  • Views 56
  • Downloads 0

How To Cite

Fátima Roque (2017). Paediatric Medicines: Formulation Considerations. Archives of Pharmacy and Pharmaceutical Sciences, 1(1), 24-27. https://europub.co.uk./articles/-A-560269